United States · Industrial & Consumer Products · USD · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for REVELATION BIOSCIENCES, INC.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -131.38% | -202.8% | 197.27% | 66.28% | 39.84% | 28.62% |
|---|---|---|---|---|---|---|
| Sector average | -213.05% | -30.99% | 76.25% | 96.15% | 83.7% | 17.59% |
| ROA | -97.93% | -125.29% | 789.01% | 180.72% | 180.62% | 181.56% |
| Total Assets | $11,582,924.00 | $2,660,343.18 | - | - | - | - |
| Net Income | -$8,913,649.00 | -$8,922,580.82 | -$8,902,966.11 | -$8,886,214.60 | -$8,881,331.14 | -$8,927,497.71 |